Atea Pharmaceuticals, Inc. Contracts & Agreements
32 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (1)
- Human Resources (19)
- Intellectual Property (1)
- Real Estate (3)
- Uncategorized (2)
- Non-Employee Director Compensation Program (Filed With SEC on August 7, 2024)
- Form of 2024 Performance-Based Restricted Stock Unit Award Agreement (Non-CEO Executive) under the 2020 Incentive Award Plan (Filed With SEC on February 28, 2024)
- Form of 2024 Performance-Based Restricted Stock Unit Award Agreement (CEO) under the 2020 Incentive Award Plan (Filed With SEC on February 28, 2024)
- Form of Non-Employee Restricted Stock Unit Award Agreement (Filed With SEC on August 8, 2023)
- Form of Non-Employee Stock Option Award Agreement (Filed With SEC on August 8, 2023)
- Non-Employee Director Compensation Program (Filed With SEC on August 8, 2023)
- Consulting Agreement dated June 10, 2022, by and between the Company and Bruce Polsky, M.D (Filed With SEC on August 8, 2022)
- Amendment to Sublease Agreement dated April 11, 2022 between the Company and DataRobot, Inc (Filed With SEC on August 8, 2022)
- Non-Employee Director Compensation Program (Filed With SEC on February 28, 2022)
- Form of Performance-Based Restricted Stock Unit Award Agreement (Non-CEO Executive) under the 2020 Incentive Award Plan (Filed With SEC on February 28, 2022)
- Form of Performance-Based Restricted Stock Unit Award Agreement (CEO) under the 2020 Incentive Award Plan (Filed With SEC on February 28, 2022)
- Sublease Agreement, dated as of July 19, 2021, by and between the Company and DataRobot, Inc (Filed With SEC on July 23, 2021)
- Consulting Agreement, dated May 18, 2021, by and between the Company and Upstream Wellness and Health LLC (Filed With SEC on May 20, 2021)
- Employment Agreement between the Company and Arantxa Horga, MD, dated November 3, 2020 (Filed With SEC on March 30, 2021)
- Employment Agreement between the Company and Wayne Foster, dated November 3, 2020 (Filed With SEC on March 30, 2021)
- Employment Agreement between the Company and John Vavricka, dated November 3, 2020 (Filed With SEC on March 30, 2021)
- Employment Agreement between the Company and Janet Hammond, MD, PhD, dated November 3, 2020 (Filed With SEC on March 30, 2021)
- Description of Capital Stock (Filed With SEC on March 30, 2021)
- Employment Agreement between the Registrant and Andrea Corcoran, dated October 25, 2020 (Filed With SEC on October 26, 2020)
- Employment Agreement between the Registrant and Jean-Pierre Sommadossi, Ph.D., dated October 25, 2020 (Filed With SEC on October 26, 2020)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on October 26, 2020)
- Non-Employee Director Compensation Program (Filed With SEC on October 26, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on October 26, 2020)
- 2020 Incentive Award Plan and form of agreements thereunder (Filed With SEC on October 26, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 26, 2020)
- License Agreement, dated as of October 21, 2020, among the Registrant, F. Hoffman-La Roche Ltd and Genentech, Inc (Filed With SEC on October 23, 2020)
- Fourth Amended and Restated Stockholders Agreement, as amended (Filed With SEC on October 23, 2020)
- Fourth Amended and Restated Stockholders Agreement (Filed With SEC on October 9, 2020)
- Consulting Agreement between the Registrant and Danforth Advisors, LLC (Filed With SEC on October 9, 2020)
- Lease Agreement between the Registrant and OPG 125 SUMMER OWNER (DE) LLC (Filed With SEC on October 9, 2020)
- 2013 Stock Incentive Plan, as amended, and form of agreements thereunder (Filed With SEC on October 9, 2020)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on October 9, 2020)
